NOV 20, 2016 08:01 PM PST

Similar Epigenetic Changes Seen in Various Types of Autism

WRITTEN BY: Carmen Leitch
A study published in Cell demonstrated how the brains of patients with different kinds of autism spectrum disorder (ASD) share common epigenetic modifications. Histone acetylation is one such type of modification, a change in a structure, a histone, which helps package DNA. 68% of patients with varying types of ASD show evidence of the same pattern of histone acetylation. This data suggests that epigenetic changes could be a common mechanism underlying a disease that has a diverse phenotype among affected individuals. 
 
Graphical Abstract / Credit: Cell 2016 Sun et al
 
"We find epigenetic changes that are present in most patients with autism spectrum disorder, or ASD," explained a co-senior author of the work, Shyam Prabhakar of the Genome Institute of Singapore. "This suggests that, despite tremendous heterogeneity in the primary causes of autism, such as DNA mutations and environmental perturbations during development, ASD has molecular features that are commonly shared. It is encouraging that ASD has common molecular changes, because this opens up the possibility of designing drugs to correct these changes."
 
While it’s thought that a wide variety of genetic characteristics and environmental influences can contribute to ASD, gene mutations have not been fund to account for a large percentage of the disorder, and the investigation of structural problems with proteins have not yielded better results. Scientists have thus expanded their search for causative factors to epigenetic modifications – alterations in gene expression that are not a result of changes in the genome.
 
Interaction of DNA (orange) with histones (blue) / Credit: Wikipedia
 
The researchers involved in this work wanted to explore modifications beyond methylation, a common epigenetic change, and looked at histone acetylation instead. The researchers, Prabhakar and co-senior study author Daniel Geschwind of UCLA, focused on an acetylation mark that has been implicated in gene activation, H3K27ac. A search for H3K27ac encompassing the entire epigenome was performed in brain tissue samples from the prefrontal cortex, temporal cortex, and cerebellar cortex, taken post-mortem from individuals with ASD and healthy control subjects that were 10 years of age and older.
 
They found that over 68% of ASD samples had a similar histone acetylation pattern at 5,000 gene loci, regardless of the wide range of causes and types of ASD. With the use of BrainSpan, an atlas for human brain development, they found that gene activation around 12 months after birth, when synapse formation and neuronal maturation occurs, was especially associated with increased acetylation levels in the ASD brain.
 
"This is the first large-scale study of how histone acetylation in the brain differs between disease and control samples, and part of a wave of new studies examining how the epigenome is perturbed in various diseases," Geschwind said. "Epigenome profiling has allowed us to see shared, unifying themes in what is often considered to be an amalgam of many different diseases rather than one single disease."
 
This exceptional study, made possible in large part because of advances in technology in recent years, suggests that epigenetic drugs, which are growing in use because of discoveries in cancer therapeutics, might be repurposed for use in the treatment of ASD. "Currently there are no approved drug treatments specifically for ASD, but we do hope that studies such as ours, as well as the downstream work that is surely needed, will eventually lead to new treatments," Prabhakar concluded.
 
The researchers would like to follow up on their results; they want to know if the epigenetic changes are causal or if they are simply associated with processes in the disease, as well as how they relate to the mechanisms of the disorder.
 


Check out the video above if you'd like to learn more about histone acetylation.
 
Sources: AAAS/Eurekalert! via Cell Press News, Cell
 
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 21, 2019
Cell & Molecular Biology
SEP 21, 2019
Could we be allergic to CRISPR?
A new study published in Nature reveals an immunity to the CRISPR-Cas9 proteins in humans...
SEP 21, 2019
Cancer
SEP 21, 2019
Skin Color Protein Used to Better Evaluate Skin Cancer
The large, complex molecules known as proteins perform many crucial functions in the human body. By carrying out diverse kinds of work in our cells, they k...
SEP 21, 2019
Cancer
SEP 21, 2019
An Ointment to Stop Skin Cancer Growth
Russian scientists are developing an ointment to undermine the growth of skin cancer, according to a review recently published in Molecules. One in three c...
SEP 21, 2019
Cell & Molecular Biology
SEP 21, 2019
Exosomes are Involved in Brain Development
Researchers have learned more about the role of exosomes in neurodevelopment....
SEP 21, 2019
Cell & Molecular Biology
SEP 21, 2019
Insight Into a Common Mechanism Underlying Some Neurodevelopmental Disorders
Mutations impacting a protein complex called SWI/SNF can cause a variety of problems. Now researchers know more about why....
SEP 21, 2019
Cell & Molecular Biology
SEP 21, 2019
A Protein Sensor That Helps a Stomach Bug Find a Good Home
A bacterial pathogen called Helicobacter pylori is known to colonize the stomach and cause ulcers....
Loading Comments...